DY Dycom Industries | $509.32 -0.1% | 5/29/2026 | | Set Price Target | $654.00 | | 00.00% | View details for Wedbush rating of Dycom Industries (NYSE:DY) on 5/29/2026 |
VOYG Voyager Technologies | $49.50 -0.1% | 5/29/2026 | | Boost Price Target | $46.00 ➝ $60.00 | Outperform | 00.00% | View details for Wedbush rating of Voyager Technologies (NYSE:VOYG) on 5/29/2026 |
OKTA Okta | $123.27
| 5/29/2026 | | Reiterated Rating | $60.00 | Outperform | 00.00% | View details for Wedbush rating of Okta (NASDAQ:OKTA) on 5/29/2026 |
BBY Best Buy | $78.16 +0.3% | 5/29/2026 | | Boost Price Target | $70.00 ➝ $75.00 | Neutral | 00.00% | View details for Wedbush rating of Best Buy (NYSE:BBY) on 5/29/2026 |
COGT Cogent Biosciences | $34.96
| 5/29/2026 | | Reiterated Rating | $55.00 | Outperform | 00.00% | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 5/29/2026 |
ESTC Elastic | $64.82 +0.2% | 5/29/2026 | | Lower Price Target | $74.00 ➝ $65.00 | Outperform | 00.00% | View details for Wedbush rating of Elastic (NYSE:ESTC) on 5/29/2026 |
IBM International Business Machines | $298.26 +0.2% | 5/29/2026 | | Reiterated Rating | $320.00 | Outperform | 00.00% | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/29/2026 |
MDB MongoDB | $335.55
| 5/29/2026 | | Boost Price Target | $380.00 ➝ $390.00 | Outperform | 00.00% | View details for Wedbush rating of MongoDB (NASDAQ:MDB) on 5/29/2026 |
NTAP NetApp | $174.29
| 5/29/2026 | | Boost Price Target | $115.00 ➝ $150.00 | Neutral | 00.00% | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 5/29/2026 |
S SentinelOne | $16.47 -0.5% | 5/29/2026 | | Reiterated Rating | $20.00 | Outperform | 00.00% | View details for Wedbush rating of SentinelOne (NYSE:S) on 5/29/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
STAA STAAR Surgical | $29.89
| 5/29/2026 | | Reiterated Rating | $40.00 | Outperform | 00.00% | View details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 5/29/2026 |
P Everpure | $79.31 -0.3% | 5/28/2026 | | Boost Price Target | $100.00 ➝ $105.00 | Outperform | 00.00% | View details for Wedbush rating of Everpure (NYSE:P) on 5/28/2026 |
SNOW Snowflake | $255.94 +0.2% | 5/28/2026 | | Boost Price Target | $270.00 ➝ $280.00 | Outperform | 00.00% | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 5/28/2026 |
CRM Salesforce | $191.00 -0.1% | 5/28/2026 | | Reiterated Rating | $325.00 | Outperform | 00.00% | View details for Wedbush rating of Salesforce (NYSE:CRM) on 5/28/2026 |
DMRA Damora Therapeutics, Inc. Common Stock | $24.88
| 5/28/2026 | | Initiated Coverage | $35.00 | Outperform | 00.00% | View details for Wedbush rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 5/28/2026 |
NUVL Nuvalent | $110.39
| 5/28/2026 | | Reiterated Rating | $125.00 | Outperform | 00.00% | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 5/28/2026 |
APGE Apogee Therapeutics | $82.14
| 5/27/2026 | | Boost Price Target | $120.00 ➝ $135.00 | Outperform | 00.00% | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 5/27/2026 |
CRBP Corbus Pharmaceuticals | $7.91
| 5/27/2026 | | Lower Price Target | $38.00 ➝ $30.00 | Outperform | 00.00% | View details for Wedbush rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/27/2026 |
CRWD CrowdStrike | $731.00
| 5/27/2026 | | Boost Price Target | $550.00 ➝ $700.00 | Outperform | 00.00% | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 5/27/2026 |
PANW Palo Alto Networks | $281.69
| 5/27/2026 | | Boost Price Target | $225.00 ➝ $300.00 | Outperform | 00.00% | View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 5/27/2026 |
RNAC Cartesian Therapeutics | $7.54
| 5/27/2026 | | Reiterated Rating | $38.00 | Outperform | 00.00% | View details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 5/27/2026 |
ZS Zscaler | $139.73
| 5/27/2026 | | Lower Price Target | $300.00 ➝ $220.00 | Outperform | 00.00% | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 5/27/2026 |
OKLO Oklo | $66.91 +0.0% | 5/26/2026 | | Reiterated Rating | $110.00 | Outperform | 00.00% | View details for Wedbush rating of Oklo (NYSE:OKLO) on 5/26/2026 |
TENB Tenable | $28.23
| 5/26/2026 | | Reiterated Rating | $29.00 | Outperform | 00.00% | View details for Wedbush rating of Tenable (NASDAQ:TENB) on 5/26/2026 |
COAG Hemab Therapeutics | $28.50
| 5/26/2026 | | Initiated Coverage | $42.00 | Outperform | 00.00% | View details for Wedbush rating of Hemab Therapeutics (NASDAQ:COAG) on 5/26/2026 |
IBM International Business Machines | $298.26 +0.2% | 5/21/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/21/2026 |
NVDA NVIDIA | $211.14
| 5/21/2026 | | Boost Price Target | $300.00 ➝ $330.00 | Outperform | 00.00% | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/21/2026 |
GLOB Globant | $40.26 -0.2% | 5/18/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of Globant (NYSE:GLOB) on 5/18/2026 |
LRMR Larimar Therapeutics | $3.48
| 5/18/2026 | | Lower Price Target | $13.00 ➝ $12.00 | Outperform | 00.00% | View details for Wedbush rating of Larimar Therapeutics (NASDAQ:LRMR) on 5/18/2026 |
NVDA NVIDIA | $211.14
| 5/18/2026 | | Reiterated Rating | $300.00 | Buy | 00.00% | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/18/2026 |
GLOB Globant | $40.26 -0.2% | 5/15/2026 | | Set Price Target | $54.00 | | 00.00% | View details for Wedbush rating of Globant (NYSE:GLOB) on 5/15/2026 |
DT Dynatrace | $42.57 -0.1% | 5/15/2026 | | Set Price Target | $48.00 | | 00.00% | View details for Wedbush rating of Dynatrace (NYSE:DT) on 5/15/2026 |
SOLV Solventum | $75.13 +0.2% | 5/15/2026 | | Initiated Coverage | $94.00 | Outperform | 00.00% | View details for Wedbush rating of Solventum (NYSE:SOLV) on 5/15/2026 |
SBUX Starbucks | $99.16
| 5/14/2026 | | Initiated Coverage | | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 5/14/2026 |
ANRO Alto Neuroscience | $20.12 +0.3% | 5/14/2026 | | Boost Price Target | $21.00 ➝ $24.00 | Neutral | 00.00% | View details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 5/14/2026 |
KLRS Kalaris Therapeutics | $5.27
| 5/14/2026 | | Initiated Coverage | $17.00 | Outperform | 00.00% | View details for Wedbush rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/14/2026 |
APRE Aprea Therapeutics | $0.89
| 5/14/2026 | | Lower Price Target | $7.00 ➝ $6.00 | Outperform | 00.00% | View details for Wedbush rating of Aprea Therapeutics (NASDAQ:APRE) on 5/14/2026 |
AVTX Avalo Therapeutics | $15.95
| 5/14/2026 | | Lower Price Target | $40.00 ➝ $34.00 | Outperform | 00.00% | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/14/2026 |
INOD Innodata | $104.98
| 5/14/2026 | | Boost Price Target | $80.00 ➝ $100.00 | Outperform | 00.00% | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 5/14/2026 |
KLRS Kalaris Therapeutics | $5.27
| 5/14/2026 | | Initiated Coverage | $17.00 | Outperform | 00.00% | View details for Wedbush rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/14/2026 |
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely
You don't need a big account to trade options.
In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up.
This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now. |
PL Planet Labs PBC | $51.18 +0.1% | 5/14/2026 | | Boost Price Target | $40.00 ➝ $50.00 | Outperform | 00.00% | View details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 5/14/2026 |
STAA STAAR Surgical | $29.89
| 5/14/2026 | | Upgrade | $26.00 ➝ $40.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 5/14/2026 |
TNGX Tango Therapeutics | $21.98
| 5/14/2026 | | Boost Price Target | $19.00 ➝ $33.00 | Outperform | 00.00% | View details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 5/14/2026 |
TSEM Tower Semiconductor | $255.23
| 5/14/2026 | | Boost Price Target | $140.00 ➝ $300.00 | Neutral | 00.00% | View details for Wedbush rating of Tower Semiconductor (NASDAQ:TSEM) on 5/14/2026 |
VOR Vor Biopharma | $14.97
| 5/14/2026 | | Boost Price Target | $15.00 ➝ $18.00 | Neutral | 00.00% | View details for Wedbush rating of Vor Biopharma (NASDAQ:VOR) on 5/14/2026 |
ORCL Oracle | $225.85 +0.0% | 5/13/2026 | | Boost Price Target | $225.00 ➝ $275.00 | Outperform | 00.00% | View details for Wedbush rating of Oracle (NYSE:ORCL) on 5/13/2026 |
PEPG PepGen | $1.50
| 5/13/2026 | | Lower Price Target | $5.00 ➝ $4.00 | Outperform | 00.00% | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 5/13/2026 |
AI C3.ai | $10.75 -0.2% | 5/13/2026 | | Reiterated Rating | $15.00 | Outperform | 00.00% | View details for Wedbush rating of C3.ai (NYSE:AI) on 5/13/2026 |
DDI DoubleDown Interactive | $11.70
| 5/13/2026 | | Lower Price Target | $21.00 ➝ $15.00 | Outperform | 00.00% | View details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 5/13/2026 |
MSFT Microsoft | $450.24
| 5/13/2026 | | Reiterated Rating | $575.00 | Outperform | 00.00% | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 5/13/2026 |
OKLO Oklo | $66.91 +0.0% | 5/13/2026 | | Reiterated Rating | $110.00 | Outperform | 00.00% | View details for Wedbush rating of Oklo (NYSE:OKLO) on 5/13/2026 |
SLDB Solid Biosciences | $7.34
| 5/13/2026 | | Lower Price Target | $17.00 ➝ $16.00 | Outperform | 00.00% | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 5/13/2026 |
CINT CI&T | $3.66 +0.4% | 5/12/2026 | | Lower Price Target | $9.00 ➝ $7.00 | Outperform | 00.00% | View details for Wedbush rating of CI&T (NYSE:CINT) on 5/12/2026 |
EIKN EIKN | $10.84
| 5/12/2026 | | Lower Price Target | $7.00 ➝ $5.00 | Underperform | 00.00% | View details for Wedbush rating of EIKN (NASDAQ:EIKN) on 5/12/2026 |
GETY Getty Images | $1.05 +0.5% | 5/12/2026 | | Reiterated Rating | $7.00 | Outperform | 00.00% | View details for Wedbush rating of Getty Images (NYSE:GETY) on 5/12/2026 |
NCMI National CineMedia | $3.14
| 5/12/2026 | | Lower Price Target | $6.50 ➝ $6.00 | Outperform | 00.00% | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 5/12/2026 |
NTLA Intellia Therapeutics | $14.07
| 5/12/2026 | | Reiterated Rating | $12.00 | Neutral | 00.00% | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/12/2026 |
USAR USA Rare Earth | $28.01
| 5/12/2026 | | Boost Price Target | $29.00 ➝ $35.00 | Outperform | 00.00% | View details for Wedbush rating of USA Rare Earth (NASDAQ:USAR) on 5/12/2026 |
ARTV Artiva Biotherapeutics | $7.93
| 5/11/2026 | | Boost Price Target | $23.00 ➝ $40.00 | Outperform | 00.00% | View details for Wedbush rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 5/11/2026 |
BUR Burford Capital | $4.63 -0.2% | 5/11/2026 | | Boost Price Target | $4.75 ➝ $5.00 | Neutral | 00.00% | View details for Wedbush rating of Burford Capital (NYSE:BUR) on 5/11/2026 |
CGON CG Oncology | $62.29
| 5/11/2026 | | Boost Price Target | $77.00 ➝ $80.00 | Outperform | 00.00% | View details for Wedbush rating of CG Oncology (NASDAQ:CGON) on 5/11/2026 |
GM General Motors | $83.39 +0.2% | 5/11/2026 | | Reiterated Rating | $95.00 | Outperform | 00.00% | View details for Wedbush rating of General Motors (NYSE:GM) on 5/11/2026 |
IMA ImageneBio | $5.88
| 5/11/2026 | | Reiterated Rating | | Underperform | 00.00% | View details for Wedbush rating of ImageneBio (NASDAQ:IMA) on 5/11/2026 |
JBIO Jade Biosciences | $21.04
| 5/11/2026 | | Boost Price Target | $24.00 ➝ $34.00 | Outperform | 00.00% | View details for Wedbush rating of Jade Biosciences (NASDAQ:JBIO) on 5/11/2026 |
NKTR Nektar Therapeutics | $64.88
| 5/11/2026 | | Lower Price Target | $95.00 ➝ $80.00 | Neutral | 00.00% | View details for Wedbush rating of Nektar Therapeutics (NASDAQ:NKTR) on 5/11/2026 |
TTD Trade Desk | $21.56
| 5/8/2026 | | Set Price Target | $23.00 ➝ $21.00 | Neutral | 00.00% | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 5/8/2026 |
COIN Coinbase Global | $189.03
| 5/8/2026 | | Set Price Target | $224.00 | | 00.00% | View details for Wedbush rating of Coinbase Global (NASDAQ:COIN) on 5/8/2026 |
AAPL Apple | $312.06
| 5/8/2026 | | Reiterated Rating | $350.00 ➝ $400.00 | Outperform | 00.00% | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 5/8/2026 |
CGEM Cullinan Therapeutics | $16.44
| 5/8/2026 | | Boost Price Target | $36.00 ➝ $37.00 | Outperform | 00.00% | View details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 5/8/2026 |
CLYM Climb Bio | $10.96
| 5/8/2026 | | Boost Price Target | $15.00 ➝ $17.00 | Outperform | 00.00% | View details for Wedbush rating of Climb Bio (NASDAQ:CLYM) on 5/8/2026 |
CRSR Corsair Gaming | $12.14
| 5/8/2026 | | Boost Price Target | $7.00 ➝ $8.00 | Outperform | 00.00% | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 5/8/2026 |
DNLI Denali Therapeutics | $21.04
| 5/8/2026 | | Lower Price Target | $25.00 ➝ $23.00 | Outperform | 00.00% | View details for Wedbush rating of Denali Therapeutics (NASDAQ:DNLI) on 5/8/2026 |
INOD Innodata | $104.98
| 5/8/2026 | | Boost Price Target | $75.00 ➝ $80.00 | Outperform | 00.00% | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 5/8/2026 |
JANX Janux Therapeutics | $14.59
| 5/8/2026 | | Lower Price Target | $45.00 ➝ $36.00 | Outperform | 00.00% | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 5/8/2026 |
MP MP Materials | $64.57 -0.2% | 5/8/2026 | | Boost Price Target | $90.00 ➝ $100.00 | Outperform | 00.00% | View details for Wedbush rating of MP Materials (NYSE:MP) on 5/8/2026 |
PRAX Praxis Precision Medicines | $349.97
| 5/8/2026 | | Boost Price Target | $130.00 ➝ $166.00 | Underperform | 00.00% | View details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 5/8/2026 |
STTK Shattuck Labs | $5.95
| 5/8/2026 | | Boost Price Target | $8.00 ➝ $11.00 | Outperform | 00.00% | View details for Wedbush rating of Shattuck Labs (NASDAQ:STTK) on 5/8/2026 |
U Unity Software | $30.40 -0.2% | 5/8/2026 | | Boost Price Target | $30.00 ➝ $32.00 | Outperform | 00.00% | View details for Wedbush rating of Unity Software (NYSE:U) on 5/8/2026 |
APP AppLovin | $613.09
| 5/7/2026 | | Reiterated Rating | $640.00 | Outperform | 00.00% | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 5/7/2026 |
BCRX BioCryst Pharmaceuticals | $8.91
| 5/7/2026 | | Lower Price Target | $22.00 ➝ $21.00 | Outperform | 00.00% | View details for Wedbush rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 5/7/2026 |
CCRN Cross Country Healthcare | $13.09
| 5/7/2026 | | Downgrade | $15.00 ➝ $13.25 | Outperform ➝ Hold | 00.00% | View details for Wedbush rating of Cross Country Healthcare (NASDAQ:CCRN) on 5/7/2026 |
DDOG Datadog | $247.35
| 5/7/2026 | | Boost Price Target | $190.00 ➝ $220.00 | Outperform | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 5/7/2026 |
FUBO fuboTV | $10.11 +0.2% | 5/7/2026 | | Lower Price Target | $24.00 ➝ $19.00 | Outperform | 00.00% | View details for Wedbush rating of fuboTV (NYSE:FUBO) on 5/7/2026 |
QLYS Qualys | $109.29
| 5/7/2026 | | Lower Price Target | $155.00 ➝ $125.00 | Outperform | 00.00% | View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 5/7/2026 |
RVMD Revolution Medicines | $157.48
| 5/7/2026 | | Boost Price Target | $165.00 | Outperform | 00.00% | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 5/7/2026 |
TASK TaskUs | $6.33
| 5/7/2026 | | Lower Price Target | $14.00 ➝ $12.00 | Outperform | 00.00% | View details for Wedbush rating of TaskUs (NASDAQ:TASK) on 5/7/2026 |
AVTX Avalo Therapeutics | $15.95
| 5/6/2026 | | Boost Price Target | $29.00 ➝ $40.00 | Outperform | 00.00% | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/6/2026 |
DNTH Dianthus Therapeutics | $93.01
| 5/6/2026 | | Boost Price Target | $103.00 ➝ $105.00 | Outperform | 00.00% | View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 5/6/2026 |
HURN Huron Consulting Group | $107.39
| 5/6/2026 | | Reiterated Rating | $160.00 | Outperform | 00.00% | View details for Wedbush rating of Huron Consulting Group (NASDAQ:HURN) on 5/6/2026 |
IBM International Business Machines | $298.26 +0.2% | 5/6/2026 | | Reiterated Rating | $320.00 | Outperform | 00.00% | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/6/2026 |
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad) The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions. See the 5 stocks to avoid |
LOGI Logitech International | $121.87
| 5/6/2026 | | Reiterated Rating | $135.00 | Outperform | 00.00% | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 5/6/2026 |
NBIX Neurocrine Biosciences | $158.30
| 5/6/2026 | | Boost Price Target | $166.00 ➝ $176.00 | Outperform | 00.00% | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/6/2026 |
PTGX Protagonist Therapeutics | $99.56
| 5/6/2026 | | Boost Price Target | $112.00 ➝ $118.00 | Outperform | 00.00% | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 5/6/2026 |
RARE Ultragenyx Pharmaceutical | $23.94
| 5/6/2026 | | Lower Price Target | $27.00 ➝ $26.00 | Neutral | 00.00% | View details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/6/2026 |
SMCI Super Micro Computer | $46.09
| 5/6/2026 | | Lower Price Target | $42.00 ➝ $34.00 | Neutral | 00.00% | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 5/6/2026 |
PAY Paymentus | $23.54 +0.2% | 5/5/2026 | | Boost Price Target | $32.00 ➝ $36.00 | Outperform | 00.00% | View details for Wedbush rating of Paymentus (NYSE:PAY) on 5/5/2026 |
TVTX Travere Therapeutics | $47.18
| 5/5/2026 | | Boost Price Target | $53.00 ➝ $55.00 | Outperform | 00.00% | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 5/5/2026 |
CATX Perspective Therapeutics | $3.94
| 5/5/2026 | | Reiterated Rating | $11.00 | Outperform | 00.00% | View details for Wedbush rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 5/5/2026 |
NUVB Nuvation Bio | $4.76 -0.4% | 5/5/2026 | | Reiterated Rating | $11.00 | Outperform | 00.00% | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 5/5/2026 |
PLTR Palantir Technologies | $156.54
| 5/5/2026 | | Reiterated Rating | $230.00 | Outperform | 00.00% | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 5/5/2026 |